They have no fiduciary duty in many cases and can profit from customers’ confusion. But where’s the line between unsavory and illegal?
Truist Financial upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Thursday morning, MarketBeat reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback